<html>
<head>PUBMED IDs for SLC39A6</head>
<body bgcolor='#C5F0F2'><h1>SLC39A6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17158757/'>Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.</a> December 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18330719/'>Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.</a> March 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18544966/'>Lost in translation? A systematic database of gene expression in breast cancer.</a> June 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19066393/'>Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia.</a> December 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21079769/'>A scale-free structure prior for graphical models with applications in functional genomics.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23644492/'>Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.</a> August 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23847371/'>SLC39A6 affects esophageal squamous cell carcinoma survival.</a> March 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23919497/'>A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).</a> November 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25253783/'>SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer.</a> August 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26444413/'>SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.</a> July 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26684241/'>miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.</a> December 15  2015<br></body></html>
